Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportPoster - PhysicianPharm

Test-Retest Reproducibility of Radiomic Features on PSMA-targeted 18F-DCFPyL PET/CT in Patients with Metastatic Prostate Cancer

Rudolf Werner, Bilel Habacha, Lena Bundschuh, Takahiro Higuchi, Sebastian Serfling, Thorsten Derlin, Markus Essler, Constantin Lapa, Kenneth Pienta, Andreas Buck, Mario Eisenberger, Mark Markowski, Martin Lodge, Martin Pomper, Michael Gorin, Steven Rowe and Ralph Bundschuh
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1353;
Rudolf Werner
1Department of Nuclear Medicine University Hospital Wurzburg Wurzburg Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bilel Habacha
2Department of Nuclear Medicine University Medical Center Bonn Bonn Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lena Bundschuh
2Department of Nuclear Medicine University Medical Center Bonn Bonn Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takahiro Higuchi
3Dentistry and Pharmaceutical Sciences Okayama University Graduate School of Medicine Okayama Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastian Serfling
1Department of Nuclear Medicine University Hospital Wurzburg Wurzburg Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thorsten Derlin
4Department of Nuclear Medicine Hannover Medical School Hannover Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Essler
5University Medical Center Bonn Department of Nuclear Medicine Bonn Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Constantin Lapa
6Nuclear Medicine Medical Faculty, University of Augsburg Augsburg Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth Pienta
7The James Buchanan Brady Urological Institute and Department of Urology Johns Hopkins University Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Buck
1Department of Nuclear Medicine University Hospital Wurzburg Wurzburg Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mario Eisenberger
8Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Medical Institutions Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Markowski
8Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Medical Institutions Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Lodge
9The Russell H Morgan Department of Radiology and Radiological Science, Division of Nuclear Medicine Johns Hopkins Medical Institutions Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Pomper
9The Russell H Morgan Department of Radiology and Radiological Science, Division of Nuclear Medicine Johns Hopkins Medical Institutions Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Gorin
10Urology Associates and UPMC Western Maryland Cumberland MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Rowe
9The Russell H Morgan Department of Radiology and Radiological Science, Division of Nuclear Medicine Johns Hopkins Medical Institutions Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ralph Bundschuh
5University Medical Center Bonn Department of Nuclear Medicine Bonn Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1353

Objectives: Prostate-specific membrane antigen (PSMA)-targeted imaging has emerged as a powerful clinical tool to detect prostate cancer (PC). Beyond conventional PET parameters, extracted mathematically quantitative features (radiomic metrics) have gained increasing interest in recent years. We aimed to evaluate 18F-DCFPyL test-retest reproducibility of radiomic features in widespread disease.

Methods: In a prospective clinical trial (NCT03793543), 23 patients with histologically proven PC underwent two 18F-DCFPyL PET scans within 7 days (mean 3.7, range 1 to 7d). Lesions in bone, lymph nodes and other organs were manually segmented on both scans and radiomic feature metrics were assessed (in total 31, including first-order parameters [e.g. kurtosis], second-order parameters [e.g. entropy, homogeneity] and higher-order parameters [e.g. busyness, coarseness, complexity, contrast, long zone emphasis]). Repeatability of quantification was determined using correlations and within- subject coefficient of variation (wCOV, in percentage; <10% indicating excellent, 10-20% good, 20-30% acceptable and >30% unacceptable reproducibility).

Results: In total, 230 lesions (177 bone, 38 lymph nodes, 15 others) were delineated in both scans. For all investigated radiomic features, a broad range of inter-scan correlation was found (R2, entropy, 0.96 to long zone emphasis, 0.09). Analyzing all lesions, the wCOVs for entropy and homogeneity were 16.0% and 12.7%, respectively, indicating good reproducibility for second-order radiomic features. The wCOV of these radiomic features derived from LN and bone metastases, however, did not show any significant differences (wCOV entropy: LN, 16.4 % vs. skeleton, 14.9 %, P=0.42; wCOV homogeneity: LN, 14.2 % vs. skeleton, 12.4 %, P=0.26). First-order parameters (kurtosis, wCOV, 8452%) and third-order parameters (wCOV: busyness, 21.7%; contrast, 90.8%; complexity, 144.9%; coarseness, 162.1% or long zone emphasis, 630.4%) demonstrated acceptable to unacceptable reproducibility.

Conclusions: Second-order parameters entropy and homogeneity demonstrated good reproducibility on 18F-DCFPyL PET with no significant difference in performance between lymphatic or osseous tumor burden, suggesting stability of these radiomic features even among different organ compartments. Second-order parameters may be the subject of future studies or clinical trials, while other radiomic metrics may not add additional information in the setting of PSMA-directed imaging.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 62, Issue supplement 1
May 1, 2021
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Test-Retest Reproducibility of Radiomic Features on PSMA-targeted 18F-DCFPyL PET/CT in Patients with Metastatic Prostate Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Test-Retest Reproducibility of Radiomic Features on PSMA-targeted 18F-DCFPyL PET/CT in Patients with Metastatic Prostate Cancer
Rudolf Werner, Bilel Habacha, Lena Bundschuh, Takahiro Higuchi, Sebastian Serfling, Thorsten Derlin, Markus Essler, Constantin Lapa, Kenneth Pienta, Andreas Buck, Mario Eisenberger, Mark Markowski, Martin Lodge, Martin Pomper, Michael Gorin, Steven Rowe, Ralph Bundschuh
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1353;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Test-Retest Reproducibility of Radiomic Features on PSMA-targeted 18F-DCFPyL PET/CT in Patients with Metastatic Prostate Cancer
Rudolf Werner, Bilel Habacha, Lena Bundschuh, Takahiro Higuchi, Sebastian Serfling, Thorsten Derlin, Markus Essler, Constantin Lapa, Kenneth Pienta, Andreas Buck, Mario Eisenberger, Mark Markowski, Martin Lodge, Martin Pomper, Michael Gorin, Steven Rowe, Ralph Bundschuh
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1353;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Poster - PhysicianPharm

  • Preliminary result of Texture Analysis on prediction of overall outcome of neuroendocrine tumors based on pre-therapy heterogeneity of somatostatin receptors on 68Ga Dotatate PET/CT scans.
  • Diagnostic value of myocardial blood flow quantitative imaging with CZT SPECT in patients with high-risk coronary artery disease
  • The Role of 18F-FDG-PET/CT Imaging in Predicting Outcome of Patients with Newly Diagnosed Multiple Myeloma
Show more Poster - PhysicianPharm

Prostate/GU

  • 177Lu-PSMA-617 versus Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer: a randomised, open-label, phase 2 trial (TheraP)
  • Initial experience with volumetric 18F-PSMA-1007 PET/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in biochemically recurrent prostate cancer
  • Factors influencing outcome post Radium 223 dichloride in castrate resistant prostate cancer- A review of some real world challenges
Show more Prostate/GU

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire